Galmed Pharmaceuticals Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.50

-0.08 (-14.16%)

As of Mar 29, 11:04 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,317.2% upside

Low Target $9.83

Average Target $17.25

High Target $23.67

Current Price $0.50

Current
$0.50

Target
$17.25

$9.83 $17.25 avg $23.67

Scenario Analysis

Bear Case

$9.83

1,847.3%

Low target

Base Case

$17.25

+3,317.2%

Avg target

Bull Case

$23.67

+4,589.0%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$2.68

-81.2% from high

52-Week Low

$0.50

+0.5% from low

Target vs 52W High

$17.25

+543.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%